Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC Nov 4, 2024 08:00AM
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies Jun 26, 2023 07:30AM
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate Jan 27, 2022 04:30PM
Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal Dec 23, 2020 08:00AM
Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity Dec 15, 2020 05:59PM


Aug 20, 2020 09:00AM IsoPlexis and Lonza Collaborate to Enable the Next Generation of Precision Cell Therapy Manufacturing
Nov 5, 2019 09:00AM Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy
Oct 16, 2019 06:17PM Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy
Dec 15, 2016 12:30AM Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries